Know Cancer

or
forgot password
  • cancer clinical trials in ann arbor, MI

  • Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Neuroblastoma
    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Prostate Cancer
    Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia
    Universtiy of Michigan
    Ann Arbor, Michigan 48109
    Chronic Myeloid Leukemia
    Optimized Intensity Modulated Irradiation for Head and Neck Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Head and Neck Cancer
    A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer
    University of Michigan Health Systems
    Ann Arbor, Michigan 48109
    Breast Cancer
    Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
    University of Michigan Comprehensive Cancer Center Deptof Endocrinology&Diabetes
    Ann Arbor, Michigan 48109-0944
    Acromegaly
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Non-Small Cell Lung Cancer
    Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen
    University of Michigan,Department of Internal Med. Hematology- Oncology
    Ann Arbor, Michigan 48109
    Multiple Myeloma, Plasma Cell Leukemia
    Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Extensive-Stage Small Cell Lung Cancer
    Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
    University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Acute Myelogenous Leukemia
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    University of Michigan Health System
    Ann Arbor, Michigan
    Hepatic Veno-Occlusive Disease
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lung Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Diffuse Large B Cell Lymphoma
    Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Bladder Cancer
    N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Neuroblastoma
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Saint Joseph Mercy Cancer Center
    Ann Arbor, Michigan 48106-0995
    Lung Cancer
    Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
    Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome
    University of Michigan, Michigan Clinical Research Unit
    Ann Arbor, Michigan 48109
    Polycystic Ovary Syndrome
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
    University of Michigan Health System
    Ann Arbor, Michigan
    Breast Neoplasms, Breast Abnormalities
    Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Breast Cancer
    Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue
    University of Michigan Health System
    Ann Arbor, Michigan
    Brain Cancer, Neck Cancer
    Breast Lesion Analysis for Tomosynthesis Mammography
    University of Michigan Health System
    Ann Arbor, Michigan
    Breast Cancer, Other (Abnormal) Findings on Radiological Examination of Breast
    Preventive Health Behavior in Women
    University of Michigan Health System
    Ann Arbor, Michigan
    Colon Cancer
    Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)
    Univeristy of Michigan Health System
    Ann Arbor, Michigan 48109
    Brain Tumors
    A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Myelofibrosis
    Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Multiple Myeloma
    The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Acute Graft Versus Host Disease
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia